Headlines

Sarepta Therapeutics (SRPT) reaffirms FY26 sales forecast between USD 1.2-1.4bln; management guides towards lower end of range

Newsquawk Staff ·

Sarepta Therapeutics (SRPT) reaffirms FY26 sales forecast between USD 1.2-1.4bln; management guides towards lower end of range.

Related headlines